Current therapeutic options for gastric adenocarcinoma
نویسندگان
چکیده
منابع مشابه
Current Treatment Options for Metastatic Pancreatic Adenocarcinoma
Pancreatic adenocarcinoma is the fourth leading cause of cancer-related death and have extremely poor prognosis. Although, declining trends for some major cancers, death rates are rising in both sexes for pancreatic cancer. Surgical resection is the only curative treatment of pancreatic cancer, but only 10 to 20 percent of patients are candidates for curative surgery. Fifty to sixty percent of ...
متن کاملGastric cancer--new therapeutic options.
Gastric and gastroesophageal adenocarcinomas are important health problems. A 2005 analysis1 of the worldwide incidence of and mortality from cancer showed that 934,000 cases of gastric cancer occurred in 2002 and that 700,000 patients die annually of this disease. The management of gastric cancer, like the management of most gastrointestinal cancers, is based on surgical resection of the prima...
متن کاملIN TRAOPERATIVE RADIATION THERAPY FOR GASTRIC ADENOCARCINOMA
Intraoperative radiation therapy (IORT) is a multidisciplinary approach in which residual tumors or tumor beds are directly irradiated during a surgical procedure. To evaluate its efficacy, from 1985, we conducted a prospective study including non-metastatic gastric adenocarcinoma treated by surgery, IORT (15 Grays) and postoperative external beam radiotherapy (44 Grays). Up to 1993, 51 ca...
متن کاملEsophageal Cancer: Current Options for Therapeutic Management.
BACKGROUND Esophageal cancer (EC) is the eighth most common cancer worldwide. A worldwide-established consensus on therapeutic pathways for EC is still missing. Debate exists on whether neoadjuvant and adjuvant treatment regimens improve the prognosis and which surgical approach reaches objective benefits. SUMMARY This article discusses the appropriate option of the current different curative...
متن کاملCurrent therapeutic options for multiple myeloma.
or the past 25 years intermittent melphalan/prednisone has been widely used in the treatment of multiple myeloma. Several drug combinations have improved the management of refractory disease. More recently, the myeloablative approach has shown promising results. The availability of different chemotherapeutic options requires particular attention to treatment strategies applied to specific disea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Saudi Journal of Biological Sciences
سال: 2021
ISSN: 1319-562X
DOI: 10.1016/j.sjbs.2021.05.060